itpr1 Search Results


93
Alomone Labs ip3r1
Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two <t>IP3R1-specific</t> siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for
Ip3r1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Anti-IP3+Receptor-1+(ITPR1)+Antibody/10__1523_slash_jneurosci__3766___11__2011-43-59-61
Average 93 stars, based on 1 article reviews
ip3r1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

95
Proteintech ip3r antibody
Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two <t>IP3R1-specific</t> siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for
Ip3r Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/ITPR1-specific+Antibody/pm40851314-123-17-30
Average 95 stars, based on 1 article reviews
ip3r antibody - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology ip3r rabbit pab
Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two <t>IP3R1-specific</t> siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for
Ip3r Rabbit Pab, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/IP3R+Rabbit+pAb/10__1016_slash_j__cjac__2026__100760-68-93-99
Average 94 stars, based on 1 article reviews
ip3r rabbit pab - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress ip3 r blocker treatment in vitro
Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two <t>IP3R1-specific</t> siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for
Ip3 R Blocker Treatment In Vitro, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/IP3+Receptor+Antibody/pm38169563-75-1-9
Average 94 stars, based on 1 article reviews
ip3 r blocker treatment in vitro - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
OriGene human ip receptor
Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two <t>IP3R1-specific</t> siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for
Human Ip Receptor, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/IP3+receptor+(ITPR1)+Human+shRNA+Plasmid+Kit/pm26868296-50-4-9
Average 92 stars, based on 1 article reviews
human ip receptor - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

91
Atlas Antibodies human itpr1
Selected antibodies to cerebellar antigens reported in patients with cerebellar ataxia
Human Itpr1, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Anti-ITPR1/pmc04574226-244-19-21
Average 91 stars, based on 1 article reviews
human itpr1 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
OriGene ship 3 r1 prfp
Selected antibodies to cerebellar antigens reported in patients with cerebellar ataxia
Ship 3 R1 Prfp, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Itpr1+Mouse+shRNA+Plasmid/pmc06026899-205-21-25
Average 90 stars, based on 1 article reviews
ship 3 r1 prfp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene ta326547

Ta326547, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Itpr1+Mouse+Monoclonal+Antibody/pmc08683082-4-9-8
Average 90 stars, based on 1 article reviews
ta326547 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

88
TargetMol p2y plc ip3 inhibitors

P2y Plc Ip3 Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Anti-IP3+Receptor+Antibody/ppr0369140-46-3-7
Average 88 stars, based on 1 article reviews
p2y plc ip3 inhibitors - by Bioz Stars, 2026-11
88/100 stars
  Buy from Supplier

92
OriGene ip3r1 shrna plasmids
A . Quantitative PCR showed chromaffin cells express all 3 of the IP3 receptor isoforms, but only 2 RyR isoforms. Mean transcript levels of <t>IP3R1</t> (0.05 ± 0.003) were approximately 4-fold higher than IP3R2 (0.01 ± 0.002) and almost 10-fold higher than IP3R3 (0.005 ± 0.004). Expression levels were compared to β-actin. B . IP3R and RyR isoforms showed a similar pattern of expression in WT and PLCε KO cells. C and D . Western blot analysis comparing the protein expression levels of IP3R1 in WT and PLCε KO cells. The intensity of IP3R1 bands (WT vs KO) were quantified relative to β-actin and were not significantly different (Student’s t-test; p = 0.6).
Ip3r1 Shrna Plasmids, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Itpr1+Mouse+shRNA+Plasmid/bio_rxiv__2024__01__03__574069-57-4-10
Average 92 stars, based on 1 article reviews
ip3r1 shrna plasmids - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

85
Thermo Fisher gene exp itpr1 mm00439917 m1
Comparative real-time PCR mRNA expression of 47 genes related to contractile function in the afferent arterioles from Notch3 −/− and wild-type littermates. Note that the expression of Cacna1h coding the α 1H subunit of the T-type Ca 2+ channel (Ca v 3.2) gene was strongly downregulated in Notch3 −/− ( p < 0.001 vs. wild-type). In contrast, Cacna1c coding the α 1C subunit of the L-type Ca 2+ channel was similarly expressed in the two strains (No. 26 on the list).
Gene Exp Itpr1 Mm00439917 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Gene+Exp%2E+Itpr1%2C+Mm00439917_m1/pmc09788231-10-6--1
Average 85 stars, based on 1 article reviews
gene exp itpr1 mm00439917 m1 - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

91
Boster Bio anti rabbit pplcg1
Comparative real-time PCR mRNA expression of 47 genes related to contractile function in the afferent arterioles from Notch3 −/− and wild-type littermates. Note that the expression of Cacna1h coding the α 1H subunit of the T-type Ca 2+ channel (Ca v 3.2) gene was strongly downregulated in Notch3 −/− ( p < 0.001 vs. wild-type). In contrast, Cacna1c coding the α 1C subunit of the L-type Ca 2+ channel was similarly expressed in the two strains (No. 26 on the list).
Anti Rabbit Pplcg1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/itpr1/Anti-Phospho-IP3R-I+(S1598)+ITPR1+Antibody/pm37028406-310-4-11
Average 91 stars, based on 1 article reviews
anti rabbit pplcg1 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

Image Search Results


Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two IP3R1-specific siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure1. siRNA-mediatedIP3R1knockdownreducescalpainactivityandstabilizesAChRclustersinC2C12cells.A,Left,Trans- fection of two IP3R1-specific siRNA sequences to C2C12 (C2-siRNA) significantly reduced IP3R1 protein level to 0.07 0.01 of normal C2C12 (C2), while no difference was detected in control RNA-treated C2C12 (C2-ctRNA; 1.07 0.08) (#, normalized to untreated C2). Right, C2C12 cells, treated as indicated in the panels and immunostained with antibody to IP3R1 (green), show markedreductioninIP3R1immunostaininginC2C12cellstreatedwithIP3R1-specificsiRNAcomparedtonormalorctRNA-treated C2C12; n 3; **p 0.01, Student’s t test. All other comparisons are not significant. B, Time course of calpain activity (#, normalized to 0 time) in C2C12 cells treated with the following: media alone (C2); carbachol (CCh; 10 M); C2/CCh with 100 M calcium (Ca 2/CCh); C2/Ca 2/CCh after control RNA (Ca 2/CCh/ctRNA); Ca 2/CCh after siRNA-mediated IP3R1 knockdown (Ca 2/CCh/siRNA);Ca 2/CChwith10Mxestospongin(Ca 2/CCh/XS);andCa 2/CChwith50M2-APB(Ca 2/CCh/2-APB). Aftertreatmentfor60min,calpainactivityforCCh,Ca 2/CCh,andCa 2/CCh/ctRNAwas2.180.11,2.770.21,and2.74 0.18-fold over untreated C2, respectively. After pretreatment of C2 with siRNA-IP3R1, XS, and 2-APB, carbachol-induced calpain activity was 1.31 0.79 (Ca 2/CCh/siRNA), 1.33 0.10 (Ca 2/CCh/XS), and 1.38 0.10 (Ca 2/CCh/2-APB), respectively, significantlylessthancontrolnotpretreated;n3,*p0.05,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant. C, Top, AChR clusters expressed in untreated and treated C2C12 cultures. AChR clusters labeled with TxR-BT were prominent in C2, Ca 2/CCh/siRNA, Ca 2/CCh/XS, and Ca 2/CCh/2-APB and visibly reduced in CCh, Ca 2/CCh, and Ca 2/CCh/ctRNA, Scale bar, 40 m. Bottom, AChR cluster density [#, high-powered field (HPF)] in cultures untreated (C2, 575.742.7) and treated for

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Control, Activity Assay, Knockdown, Labeling, Immunofluorescence, Western Blot

Figure 2. Reduced expression IP3R1 in tibialis anterior and neuromuscular junction by siRNA-mediated IP3R1 knockdown. A, Left, Transfection TA muscle with GFP-specific siRNA sequence and GFPplasmidsignificantlyreducedGFPproteinlevelto0.160.01ofGFP-electroporatedTAmuscleonday5,whilenodifferencewasdetectedincontrolRNA-treated,GFP-transfectedTAmuscle (ctRNA-5 d; 1.04 0.09). Fifteen days after electroporation of TA with GFP-siRNA and GFP plasmid (siRNA,15 d), GFP protein level returned to 0.95 0.03 of GFP-plasmid transfected TA (#, normalized to only GFP-expressed TA muscle on days 5). Right, TA muscle treated as indicated in panels and compared to normal GFP-expressed TA muscle. GFP fluorescence showed remarkable reductioninTAmuscletreatedwithGFP-specificsiRNA;n3;*p0.01,Student’sttest.Allothercomparisonsarenotsignificant.B,ElectroporationoftwoIP3R1-specificsiRNAsequences(S1and S2) into TA muscle diminished IP3R1 expression maximally between days 7 and 9. IP3R1 protein level (#, normalized to untreated) was reduced to 0.11 0.02 and 0.15 0.02% of untreated on days7and9,respectively,andrecovered0.990.06%onday14;n9,**p0.001,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant.C,IP3R1immunostainedwithantibodyto IP3R1(green)colocalizeswithNMJlabeledwithTxR-BT(red)andsurroundedbysubsynapticDAPI-labelednuclei(blue)inWTandctRNA-treatednormalTAmuscle.ExpressionofIP3R1atNMJwas nearly eliminated in all nine TA muscles electroporated with IP3R1 siRNA. Scale bar, 12 m. D, Immunostaining of IP3R1 (green) does not colocalize with synaptophysin (red), a subsarcolemmal region, and does not colocalize with S100 protein (red, middle right panel), When labeled for AChRs with TxR-BT, muscle electroporated with GFP-ctRNA shows the RNA in the subsarcolemmal region surrounding the TxR-BT-labeled endplates (red, far right panel). Scale bar, 12 m.

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure 2. Reduced expression IP3R1 in tibialis anterior and neuromuscular junction by siRNA-mediated IP3R1 knockdown. A, Left, Transfection TA muscle with GFP-specific siRNA sequence and GFPplasmidsignificantlyreducedGFPproteinlevelto0.160.01ofGFP-electroporatedTAmuscleonday5,whilenodifferencewasdetectedincontrolRNA-treated,GFP-transfectedTAmuscle (ctRNA-5 d; 1.04 0.09). Fifteen days after electroporation of TA with GFP-siRNA and GFP plasmid (siRNA,15 d), GFP protein level returned to 0.95 0.03 of GFP-plasmid transfected TA (#, normalized to only GFP-expressed TA muscle on days 5). Right, TA muscle treated as indicated in panels and compared to normal GFP-expressed TA muscle. GFP fluorescence showed remarkable reductioninTAmuscletreatedwithGFP-specificsiRNA;n3;*p0.01,Student’sttest.Allothercomparisonsarenotsignificant.B,ElectroporationoftwoIP3R1-specificsiRNAsequences(S1and S2) into TA muscle diminished IP3R1 expression maximally between days 7 and 9. IP3R1 protein level (#, normalized to untreated) was reduced to 0.11 0.02 and 0.15 0.02% of untreated on days7and9,respectively,andrecovered0.990.06%onday14;n9,**p0.001,Mann–WhitneyUtest.Allothercomparisonsarenotsignificant.C,IP3R1immunostainedwithantibodyto IP3R1(green)colocalizeswithNMJlabeledwithTxR-BT(red)andsurroundedbysubsynapticDAPI-labelednuclei(blue)inWTandctRNA-treatednormalTAmuscle.ExpressionofIP3R1atNMJwas nearly eliminated in all nine TA muscles electroporated with IP3R1 siRNA. Scale bar, 12 m. D, Immunostaining of IP3R1 (green) does not colocalize with synaptophysin (red), a subsarcolemmal region, and does not colocalize with S100 protein (red, middle right panel), When labeled for AChRs with TxR-BT, muscle electroporated with GFP-ctRNA shows the RNA in the subsarcolemmal region surrounding the TxR-BT-labeled endplates (red, far right panel). Scale bar, 12 m.

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Expressing, Knockdown, Transfection, Sequencing, Electroporation, Plasmid Preparation, Fluorescence, Muscles, Immunostaining, Labeling, Immunofluorescence, Western Blot

Figure 3. siRNA-mediated IP3R1 silencing alters presynaptic and postsynaptic components of neuromuscular transmission. A. Left, Representative traces of MEPCs in ctRNA-treated (top, black)andIP3R1-siRNA-treated(bottom,blue)normaltibialisanteriormusclevoltageclamped at 60 mV. Right, The frequency of spontaneous MEPC was significantly increased in IP3R1- siRNA-treatedmusclecomparedwithctRNA-treatedTA(n29)(3.110.26s 1;n49vs 1.4 0.09 s 1; n 29, **p 0.001). B, MEPC amplitudes from IP3R1-siRNA-treated TA muscle (3.86 0.32 nA; n 25) were nearly 2-fold greater than those recorded from ctRNA- treatedTAmuscle(2.530.29nA;n19,*p0.05).C,TheMEPC( )inIP3R1-siRNA-treated TA muscle (1.5 0.08 ms; n 25) was significantly increased compared with that of ctRNA (1.140.15ms;n19,*p0.05).D,EPCamplitudeofIP3R1-siRNA-treatedTAmusclewas significantgreaterthanthatofthectRNA-treatedmuscle(50.215.9nA;n26vs13.72 2.8 nA; **p 0.001, n 26). E, The quantal content of evoked transmitter release was significantlyincreasedinIP3R1-siRNA-treatedTAmusclecomparedwithctRNA-treatedmuscle (34.21.8vs26.083.96,*p0.05)andincreasedby30%(n26).Insetshowsrawdata traceofEPCforIP3R1-siRNA-treatedandctRNA-treatedmuscle;n#ofendplates.Mouse# 10.AllcomparisonswereanalyzedbyStudent’sttest.Allothercomparisonsarenotsignificant.

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure 3. siRNA-mediated IP3R1 silencing alters presynaptic and postsynaptic components of neuromuscular transmission. A. Left, Representative traces of MEPCs in ctRNA-treated (top, black)andIP3R1-siRNA-treated(bottom,blue)normaltibialisanteriormusclevoltageclamped at 60 mV. Right, The frequency of spontaneous MEPC was significantly increased in IP3R1- siRNA-treatedmusclecomparedwithctRNA-treatedTA(n29)(3.110.26s 1;n49vs 1.4 0.09 s 1; n 29, **p 0.001). B, MEPC amplitudes from IP3R1-siRNA-treated TA muscle (3.86 0.32 nA; n 25) were nearly 2-fold greater than those recorded from ctRNA- treatedTAmuscle(2.530.29nA;n19,*p0.05).C,TheMEPC( )inIP3R1-siRNA-treated TA muscle (1.5 0.08 ms; n 25) was significantly increased compared with that of ctRNA (1.140.15ms;n19,*p0.05).D,EPCamplitudeofIP3R1-siRNA-treatedTAmusclewas significantgreaterthanthatofthectRNA-treatedmuscle(50.215.9nA;n26vs13.72 2.8 nA; **p 0.001, n 26). E, The quantal content of evoked transmitter release was significantlyincreasedinIP3R1-siRNA-treatedTAmusclecomparedwithctRNA-treatedmuscle (34.21.8vs26.083.96,*p0.05)andincreasedby30%(n26).Insetshowsrawdata traceofEPCforIP3R1-siRNA-treatedandctRNA-treatedmuscle;n#ofendplates.Mouse# 10.AllcomparisonswereanalyzedbyStudent’sttest.Allothercomparisonsarenotsignificant.

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Transmission Assay, Patch Clamp

Figure 4. IP3R1 activity controls synaptic gene expression in muscle. A, AChR intensity (TxR-BT fluorescence intensity; #, normalizedtountreated)atWTNMJaftertreatmentwithsiRNA(siRNA-WT)forIP3R1knockdown(9d)is1.760.18-foldgreater than untreated, a significant increase compared with untreated (n 7; ***p 0.001), while ctRNA (ctRNA-WT) had no effect (n 7; p 0.81). After denervation (Dv), the AChR intensity was increased by 2.79 0.58-fold, significantly greater than untreated (n 7; ***p 0.001). B, Time course of expression (#, normalized to 0 time expression) of and subunit after denervation (left graph), or after siRNA silencing of IP3R1 (right graph). Expression levels at day 9 after siRNA for subunit (11.12 1.83) and subunit (63.48 6.49) were significantly greater than the corresponding values for ctRNA-treated TA muscle(n5;p0.005).C,Expressionlevels(#,normalizedto0timeexpression)ofNMJgenes,AChR subunit(delta),AChR subunit (), acetylcholinesterase (AChE), ErbB2, MuSK, and rapsyn in TA muscle. Expression levels at day 9 after siRNA for subunit(3.070.64;**p0.005)andsubunit(1.520.16;**p0.005)weresignificantlygreaterthanthecorresponding valuesforctRNA-treatedTAmuscle(n5).Treatmentwithdenervationfor3d(DV-3d-WT),IP3R1knockdownfor9d(siRNA-9d- WT), combined denervation and IP3R1 knockdown (DV-3d-siRNA-9d-WT), or ctRNA for 9 d (ctRNA-WT) showed similar but not identical effects of the two treatments on gene expression. Combined treatments showed that effects are overlapping. ***p 0.001.D,Expressionlevels(#,normalizedto0timeexpression)ofmusclegenes,Glut1andGlut4,inTAmuscleaftertreatmentwith denervation for 3 d (DV-3d-WT), IP3R1 knockdown for 9 d (siRNA-9d-WT), combined denervation and IP3R1 knockdown (DV-3d- siRNA-9d-WT), or ctRNA for 9 d (ctRNA-WT) showed that IP3R1 had no effect on non NMJ muscle gene expression compared with denervation.ComparedtoWT,expressionofGlut1/4wasunchangedinsiRNA-9d-WTandctRNA-9d-WT,whereasGlut1expression was 15-fold to WT in Dv-3d-siRNA-9d-WT and in Dv-3d-WT. ctRNA had no effect on gene expression; n 5; **p 0.005, ***p 0.001. E, Expression levels (#, normalized to 0 time expression) of regulatory genes, myogenin, Dach2, and HCAC4 in TA muscleaftertreatmentwithdenervationfor3d(DV-3d-WT),IP3R1knockdownfor9d(siRNA-9d-WT),combineddenervationand IP3R1knockdown(DV-3d-siRNA-9d-WT),orctRNAfor9d(ctRNA-WT)demonstratedthatcomparableeffectsonregulatorygenes was significantly increased by IP3R1 knockdown and denervation. ctRNA had no effect on gene expression; n 5; **p 0.005, ***p 0.001. F, Left, Immunolocalization of HDAC4 in subsynaptic nuclei of wild-type (WT), denervated (Dv), siRNA-treated (siRNA), and control RNA-treated (ctRNA) TA muscle colabeled with TxR-BT (red) and DAPI (blue) to label nuclei shows that HDAC4(green)islocalizedatandsurroundingNMJsinallfourpanels,butinadditionshowscolocalizationwithsubsynapticnuclei (light blue stain) in denervated and siRNA-treated TA muscle (arrows). Scale bar, 15 m. Right, Quantification of HDAC4 immu- nolabeling in subsynaptic nuclei (SN) and extrajunctional nuclei (EN) showed that the percentage of HDAC4-labeled subsynaptic nuclei(HDAC4-SN)indenervatedTAmuscle(Dv-3d-WT)andsiRNA-9d-WTwere12.070.73and7.360.29%,respectively,

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure 4. IP3R1 activity controls synaptic gene expression in muscle. A, AChR intensity (TxR-BT fluorescence intensity; #, normalizedtountreated)atWTNMJaftertreatmentwithsiRNA(siRNA-WT)forIP3R1knockdown(9d)is1.760.18-foldgreater than untreated, a significant increase compared with untreated (n 7; ***p 0.001), while ctRNA (ctRNA-WT) had no effect (n 7; p 0.81). After denervation (Dv), the AChR intensity was increased by 2.79 0.58-fold, significantly greater than untreated (n 7; ***p 0.001). B, Time course of expression (#, normalized to 0 time expression) of and subunit after denervation (left graph), or after siRNA silencing of IP3R1 (right graph). Expression levels at day 9 after siRNA for subunit (11.12 1.83) and subunit (63.48 6.49) were significantly greater than the corresponding values for ctRNA-treated TA muscle(n5;p0.005).C,Expressionlevels(#,normalizedto0timeexpression)ofNMJgenes,AChR subunit(delta),AChR subunit (), acetylcholinesterase (AChE), ErbB2, MuSK, and rapsyn in TA muscle. Expression levels at day 9 after siRNA for subunit(3.070.64;**p0.005)andsubunit(1.520.16;**p0.005)weresignificantlygreaterthanthecorresponding valuesforctRNA-treatedTAmuscle(n5).Treatmentwithdenervationfor3d(DV-3d-WT),IP3R1knockdownfor9d(siRNA-9d- WT), combined denervation and IP3R1 knockdown (DV-3d-siRNA-9d-WT), or ctRNA for 9 d (ctRNA-WT) showed similar but not identical effects of the two treatments on gene expression. Combined treatments showed that effects are overlapping. ***p 0.001.D,Expressionlevels(#,normalizedto0timeexpression)ofmusclegenes,Glut1andGlut4,inTAmuscleaftertreatmentwith denervation for 3 d (DV-3d-WT), IP3R1 knockdown for 9 d (siRNA-9d-WT), combined denervation and IP3R1 knockdown (DV-3d- siRNA-9d-WT), or ctRNA for 9 d (ctRNA-WT) showed that IP3R1 had no effect on non NMJ muscle gene expression compared with denervation.ComparedtoWT,expressionofGlut1/4wasunchangedinsiRNA-9d-WTandctRNA-9d-WT,whereasGlut1expression was 15-fold to WT in Dv-3d-siRNA-9d-WT and in Dv-3d-WT. ctRNA had no effect on gene expression; n 5; **p 0.005, ***p 0.001. E, Expression levels (#, normalized to 0 time expression) of regulatory genes, myogenin, Dach2, and HCAC4 in TA muscleaftertreatmentwithdenervationfor3d(DV-3d-WT),IP3R1knockdownfor9d(siRNA-9d-WT),combineddenervationand IP3R1knockdown(DV-3d-siRNA-9d-WT),orctRNAfor9d(ctRNA-WT)demonstratedthatcomparableeffectsonregulatorygenes was significantly increased by IP3R1 knockdown and denervation. ctRNA had no effect on gene expression; n 5; **p 0.005, ***p 0.001. F, Left, Immunolocalization of HDAC4 in subsynaptic nuclei of wild-type (WT), denervated (Dv), siRNA-treated (siRNA), and control RNA-treated (ctRNA) TA muscle colabeled with TxR-BT (red) and DAPI (blue) to label nuclei shows that HDAC4(green)islocalizedatandsurroundingNMJsinallfourpanels,butinadditionshowscolocalizationwithsubsynapticnuclei (light blue stain) in denervated and siRNA-treated TA muscle (arrows). Scale bar, 15 m. Right, Quantification of HDAC4 immu- nolabeling in subsynaptic nuclei (SN) and extrajunctional nuclei (EN) showed that the percentage of HDAC4-labeled subsynaptic nuclei(HDAC4-SN)indenervatedTAmuscle(Dv-3d-WT)andsiRNA-9d-WTwere12.070.73and7.360.29%,respectively,

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Activity Assay, Gene Expression, Fluorescence, Expressing, Knockdown, Control, Staining, Labeling, CRISPR

Figure 6. Decremental responses in rsEMG in SCS transgenic mouse and neostigmine my- opathy depend on IP3R1 activity. Top, Compound muscle action potentials recorded during repetitive stimulation (rsEMG) in WT, neostigmine myopathy (Neo-WT), SCS, and SCS treated with siRNA to knockdown IP3R1. Decremental responses are seen in both SCS and Neo-WT. Bottom, Quantitation of decrement in rsEMG in WT, neostigmine myopathy, and SCS under indicated conditions. Decrement in WT rsEMG is only 2.06 1.28% but is significantly in- creasedinneostigminemyopathy(Neo-WT,10.551.12%)andSCS(14.751.37%).IP3R1 silencingbysiRNAreducesdecrementto5.550.73%inneostigminemyopathyand7.48 1.14% in SCS. ctRNA had no effect in either condition. Blockade of IP3R1 by 2-APB reduced decrementto8.002.07%,whilesalinehadnoeffect;n5;*p0.005,Mann–WhitneyU test. All other comparisons not significant.

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure 6. Decremental responses in rsEMG in SCS transgenic mouse and neostigmine my- opathy depend on IP3R1 activity. Top, Compound muscle action potentials recorded during repetitive stimulation (rsEMG) in WT, neostigmine myopathy (Neo-WT), SCS, and SCS treated with siRNA to knockdown IP3R1. Decremental responses are seen in both SCS and Neo-WT. Bottom, Quantitation of decrement in rsEMG in WT, neostigmine myopathy, and SCS under indicated conditions. Decrement in WT rsEMG is only 2.06 1.28% but is significantly in- creasedinneostigminemyopathy(Neo-WT,10.551.12%)andSCS(14.751.37%).IP3R1 silencingbysiRNAreducesdecrementto5.550.73%inneostigminemyopathyand7.48 1.14% in SCS. ctRNA had no effect in either condition. Blockade of IP3R1 by 2-APB reduced decrementto8.002.07%,whilesalinehadnoeffect;n5;*p0.005,Mann–WhitneyU test. All other comparisons not significant.

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Transgenic Assay, Activity Assay, Knockdown, Quantitation Assay

Figure 7. siRNA-mediated IP3R1 silencing alters SCS presynaptic and postsynaptic compo- nentsofneuromusculartransmission.A,Left,RepresentativetracesofMEPCsinctRNA-treated andsiRNA-treatedSCSmousetibialisanteriormuscleendplates,voltageclampedat60mV. Right, The frequency of spontaneous MEPC was significantly increased in IP3R1-siRNA-treated muscle (n 20) compared with ctRNA-treated TA (n 19) (1.75 0.1 s 1 vs 0.78 0.04 s 1, ***p 0.001). B, MEPC amplitudes from IP3R1-siRNA-treated SCS TA muscle (1.63 0.19,n20)werenearly47%greaterthanthoserecordedfromctRNA-treatedSCSTAmuscle (1.11 0.12, n 10; *p 0.03). C, The MEPC ( ) in IP3R1-siRNA-treated TA (14.04 2.89 ms, n 13) remained prolonged and unchanged compared with that of ctRNA-treated SCS, consistent with the presence of the SCS mutation L269F (13.72 2.85 ms, n 7). D, EPC amplitudeofIP3R1-siRNA-treatedTAmuscle(n13)wassignificantlygreaterthanthatofthe ctRNA-treated muscle (45.59 6.45 nA; n 13 vs 13.72 2.8 nA; n 7; **p 0.003). E, The computed quantal content of evoked transmitter release was nearly doubled in IP3R1- siRNA-treated SCS TA muscle compared with ctRNA-treated muscle (28.3 4.6; n 13 vs 12.552.32;n7,*p0.03).InsetshowsaveragetracesofMEPCandEPCforIP3R1-siRNA- treated and ctRNA-treated SCS endplates; n # of endplates. Mouse # 4. All comparisons were analyzed by Student’s t test. All other comparisons not significant.

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure 7. siRNA-mediated IP3R1 silencing alters SCS presynaptic and postsynaptic compo- nentsofneuromusculartransmission.A,Left,RepresentativetracesofMEPCsinctRNA-treated andsiRNA-treatedSCSmousetibialisanteriormuscleendplates,voltageclampedat60mV. Right, The frequency of spontaneous MEPC was significantly increased in IP3R1-siRNA-treated muscle (n 20) compared with ctRNA-treated TA (n 19) (1.75 0.1 s 1 vs 0.78 0.04 s 1, ***p 0.001). B, MEPC amplitudes from IP3R1-siRNA-treated SCS TA muscle (1.63 0.19,n20)werenearly47%greaterthanthoserecordedfromctRNA-treatedSCSTAmuscle (1.11 0.12, n 10; *p 0.03). C, The MEPC ( ) in IP3R1-siRNA-treated TA (14.04 2.89 ms, n 13) remained prolonged and unchanged compared with that of ctRNA-treated SCS, consistent with the presence of the SCS mutation L269F (13.72 2.85 ms, n 7). D, EPC amplitudeofIP3R1-siRNA-treatedTAmuscle(n13)wassignificantlygreaterthanthatofthe ctRNA-treated muscle (45.59 6.45 nA; n 13 vs 13.72 2.8 nA; n 7; **p 0.003). E, The computed quantal content of evoked transmitter release was nearly doubled in IP3R1- siRNA-treated SCS TA muscle compared with ctRNA-treated muscle (28.3 4.6; n 13 vs 12.552.32;n7,*p0.03).InsetshowsaveragetracesofMEPCandEPCforIP3R1-siRNA- treated and ctRNA-treated SCS endplates; n # of endplates. Mouse # 4. All comparisons were analyzed by Student’s t test. All other comparisons not significant.

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Mutagenesis, Patch Clamp, Knockdown

Figure 8. IP3R1 silencing improves motor function in SCS mice. A, Hindlimb motor time interval parameters measured in motorized treadmill (DigiGait) in WT and SCS mice and the effect of unilateral IP3R1 silencing. Functional parameters termed “swing”, “brake”, and “pro- pel” are time intervals for three components of normal leg movements recorded during walk- ing;asdefinedinMaterialsandMethods,theseareidenticalbetweenleftandrighthindlimbin WTmice.AllthreeparametersaresymmetricallyandsignificantlyincreasedinSCSmice.siRNA treatment of left hindlimb TA causes significant improvement in each of these parameters in comparison to the contralateral right hindlimb, which was treated with ctRNA; n 11; *p 0.001, Student’s t test. All other comparisons not significant. B, Mean hindlimb stride length andstepfrequencyinWTandSCSandtheeffectofunilateralIP3R1silencing.Theaveragestride length for both limbs in SCS is significantly longer than WT, while the step frequency is lower. siRNA treatment of the left TA of the SCS mice reduced the stride length to that of WT and increasedthestepfrequencytoslightlygreaterthanthatofWT;n11;*p0.001,Student’s t test. All other comparisons not significant.

Journal: Journal of Neuroscience

Article Title: Skeletal Muscle IP3R1 Receptors Amplify Physiological and Pathological Synaptic Calcium Signals

doi: 10.1523/jneurosci.3766-11.2011

Figure Lengend Snippet: Figure 8. IP3R1 silencing improves motor function in SCS mice. A, Hindlimb motor time interval parameters measured in motorized treadmill (DigiGait) in WT and SCS mice and the effect of unilateral IP3R1 silencing. Functional parameters termed “swing”, “brake”, and “pro- pel” are time intervals for three components of normal leg movements recorded during walk- ing;asdefinedinMaterialsandMethods,theseareidenticalbetweenleftandrighthindlimbin WTmice.AllthreeparametersaresymmetricallyandsignificantlyincreasedinSCSmice.siRNA treatment of left hindlimb TA causes significant improvement in each of these parameters in comparison to the contralateral right hindlimb, which was treated with ctRNA; n 11; *p 0.001, Student’s t test. All other comparisons not significant. B, Mean hindlimb stride length andstepfrequencyinWTandSCSandtheeffectofunilateralIP3R1silencing.Theaveragestride length for both limbs in SCS is significantly longer than WT, while the step frequency is lower. siRNA treatment of the left TA of the SCS mice reduced the stride length to that of WT and increasedthestepfrequencytoslightlygreaterthanthatofWT;n11;*p0.001,Student’s t test. All other comparisons not significant.

Article Snippet: GFP-tagged control siRNA was purchased from Santa Cruz Biotechnology Primary antibodies were used against the following targets: neural filament (1:1000; Abcam), phosphorylated H2AX (Ser139; 1:500; Millipore), cleaved caspase 3 and 9 (1:200;Cell Signaling Technology), synaptophysin (1:500; Cell Signaling Technology), S100 (1:100; Abcam), histone deacetylase 4 (HDAC4; 1:500; Abcam), glial fibrillary acidic protein (1:500; Cell Signaling Technology), fibronectin (1:500; Abcam), IP3R1 (1:500; Alomone), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH; 1:5000; Ambion).

Techniques: Functional Assay, Comparison

Selected antibodies to cerebellar antigens reported in patients with cerebellar ataxia

Journal: Journal of Neuroinflammation

Article Title: ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII

doi: 10.1186/s12974-015-0356-y

Figure Lengend Snippet: Selected antibodies to cerebellar antigens reported in patients with cerebellar ataxia

Article Snippet: Fig. 6 Expression of ITPR1 in the human cerebellum as demonstrated by IHC using an affinity-isolated rabbit antibody to human ITPR1 (Atlas antibodies, HPA016487).

Techniques: Virus

Expression of ITPR1 in the human cerebellum as demonstrated by IHC using an affinity-isolated rabbit antibody to human ITPR1 (Atlas antibodies, HPA016487). Modified image from the Human Protein Atlas image database

Journal: Journal of Neuroinflammation

Article Title: ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII

doi: 10.1186/s12974-015-0356-y

Figure Lengend Snippet: Expression of ITPR1 in the human cerebellum as demonstrated by IHC using an affinity-isolated rabbit antibody to human ITPR1 (Atlas antibodies, HPA016487). Modified image from the Human Protein Atlas image database

Article Snippet: Fig. 6 Expression of ITPR1 in the human cerebellum as demonstrated by IHC using an affinity-isolated rabbit antibody to human ITPR1 (Atlas antibodies, HPA016487).

Techniques: Expressing, Isolation, Modification

Binding of IgG from a patient with ITPR1-Ab-positive ACA as determined in a recombinant cell-based assay to formalin-fixed rat cerebellum tissue. Human IgG was detected using a goat anti-human IgG secondary antibody labelled with Alexa Fluor®488 (green fluorescence)

Journal: Journal of Neuroinflammation

Article Title: ‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII

doi: 10.1186/s12974-015-0356-y

Figure Lengend Snippet: Binding of IgG from a patient with ITPR1-Ab-positive ACA as determined in a recombinant cell-based assay to formalin-fixed rat cerebellum tissue. Human IgG was detected using a goat anti-human IgG secondary antibody labelled with Alexa Fluor®488 (green fluorescence)

Article Snippet: Fig. 6 Expression of ITPR1 in the human cerebellum as demonstrated by IHC using an affinity-isolated rabbit antibody to human ITPR1 (Atlas antibodies, HPA016487).

Techniques: Binding Assay, Recombinant, Cell Based Assay, Fluorescence

Journal: eLife

Article Title: 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function

doi: 10.7554/eLife.66973

Figure Lengend Snippet:

Article Snippet: Antibody , Anti-Itpr1 (mouse monoclonal) , Origene , Origene: TA326547 , (1:500).

Techniques: Generated, Recombinant, Construct, Sequencing, Methylation Sequencing

Journal: eLife

Article Title: 5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function

doi: 10.7554/eLife.66973

Figure Lengend Snippet:

Article Snippet: Antibody , Anti-Itpr1 (mouse monoclonal) , Origene , Origene: TA326547 , (1:500).

Techniques:

A . Quantitative PCR showed chromaffin cells express all 3 of the IP3 receptor isoforms, but only 2 RyR isoforms. Mean transcript levels of IP3R1 (0.05 ± 0.003) were approximately 4-fold higher than IP3R2 (0.01 ± 0.002) and almost 10-fold higher than IP3R3 (0.005 ± 0.004). Expression levels were compared to β-actin. B . IP3R and RyR isoforms showed a similar pattern of expression in WT and PLCε KO cells. C and D . Western blot analysis comparing the protein expression levels of IP3R1 in WT and PLCε KO cells. The intensity of IP3R1 bands (WT vs KO) were quantified relative to β-actin and were not significantly different (Student’s t-test; p = 0.6).

Journal: bioRxiv

Article Title: A PACAP-activated network for secretion requires coordination of Ca 2+ influx and Ca 2+ mobilization

doi: 10.1101/2024.01.03.574069

Figure Lengend Snippet: A . Quantitative PCR showed chromaffin cells express all 3 of the IP3 receptor isoforms, but only 2 RyR isoforms. Mean transcript levels of IP3R1 (0.05 ± 0.003) were approximately 4-fold higher than IP3R2 (0.01 ± 0.002) and almost 10-fold higher than IP3R3 (0.005 ± 0.004). Expression levels were compared to β-actin. B . IP3R and RyR isoforms showed a similar pattern of expression in WT and PLCε KO cells. C and D . Western blot analysis comparing the protein expression levels of IP3R1 in WT and PLCε KO cells. The intensity of IP3R1 bands (WT vs KO) were quantified relative to β-actin and were not significantly different (Student’s t-test; p = 0.6).

Article Snippet: The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Cat# TR30015) is 5’-GCACTACCAGAGCTAACTCAGATAGTACT-3’, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Cat# TF517036) is 5’-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3’, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors.

Techniques: Real-time Polymerase Chain Reaction, Expressing, Western Blot

A . Confocal images showing immunostaining for the ER marker KDEL (green) and IP3R1 (red) in a chromaffin cell. Nuclei labeled with DAPI (blue). B and C . KDEL and IP3R1 intensities along the lines were similar. D . Manders’ coefficient analysis for the colocalization of KDEL and IP3R1 in n = 25 cells. Coefficient for IP3R1 overlap with KDEL = 0.7 ± 0.02; coefficient for KDEL overlap with IP3R1 = 0.8 ± 0.02.

Journal: bioRxiv

Article Title: A PACAP-activated network for secretion requires coordination of Ca 2+ influx and Ca 2+ mobilization

doi: 10.1101/2024.01.03.574069

Figure Lengend Snippet: A . Confocal images showing immunostaining for the ER marker KDEL (green) and IP3R1 (red) in a chromaffin cell. Nuclei labeled with DAPI (blue). B and C . KDEL and IP3R1 intensities along the lines were similar. D . Manders’ coefficient analysis for the colocalization of KDEL and IP3R1 in n = 25 cells. Coefficient for IP3R1 overlap with KDEL = 0.7 ± 0.02; coefficient for KDEL overlap with IP3R1 = 0.8 ± 0.02.

Article Snippet: The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Cat# TR30015) is 5’-GCACTACCAGAGCTAACTCAGATAGTACT-3’, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Cat# TF517036) is 5’-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3’, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors.

Techniques: Immunostaining, Marker, Labeling

A . Western blot showing IP3R1 immunoreactive bands in control (scrambled shRNA) and IP3R1 KD samples. B . Intensity IP3R1 was normalized to β-actin expression. Relative intensities of bands (means ± SEM) of scrambled = 1 ± 0.007 and KD = 0.4 ± 0.06. Differences were statistically significant (Student’s t-test; p = 0.01). C . Representative traces of PACAP-stimulated Cal-520 fluorescence changes in control (untransfected) cells, scrambled shRNA, IP3R1 KD cells. D . Scatter plot of total spike area (n=49 control; n=17 scrambled shRNA; n=29 IP3R1 shRNA) represented as medians ± interquartile range. A Kruskal-Wallis test was used to assess statistical significance of differences. Control vs IP3R1 KD, p = 2×10 -9 ; IP3R1 KD vs scrambled, p = 0.0003. E . Scatter plot of max amplitude are represented as medians ± interquartile range. A Kruskal-Wallis test was used to assess statistical significance of differences. Control vs IP3R1 KD, p = 7×10 -9 ; IP3R1 KD vs scrambled, p = 3×10 -5 . F . FFN511 release was measured in cells stimulated by PACAP. Responses were reported as fusion events per unit area. n=12 cells for scrambled shRNA and n=13 cells for IP3R1 shRNA. Differences between groups were statistically significant (Mann-Whitney, p = 7×10 -7 ).

Journal: bioRxiv

Article Title: A PACAP-activated network for secretion requires coordination of Ca 2+ influx and Ca 2+ mobilization

doi: 10.1101/2024.01.03.574069

Figure Lengend Snippet: A . Western blot showing IP3R1 immunoreactive bands in control (scrambled shRNA) and IP3R1 KD samples. B . Intensity IP3R1 was normalized to β-actin expression. Relative intensities of bands (means ± SEM) of scrambled = 1 ± 0.007 and KD = 0.4 ± 0.06. Differences were statistically significant (Student’s t-test; p = 0.01). C . Representative traces of PACAP-stimulated Cal-520 fluorescence changes in control (untransfected) cells, scrambled shRNA, IP3R1 KD cells. D . Scatter plot of total spike area (n=49 control; n=17 scrambled shRNA; n=29 IP3R1 shRNA) represented as medians ± interquartile range. A Kruskal-Wallis test was used to assess statistical significance of differences. Control vs IP3R1 KD, p = 2×10 -9 ; IP3R1 KD vs scrambled, p = 0.0003. E . Scatter plot of max amplitude are represented as medians ± interquartile range. A Kruskal-Wallis test was used to assess statistical significance of differences. Control vs IP3R1 KD, p = 7×10 -9 ; IP3R1 KD vs scrambled, p = 3×10 -5 . F . FFN511 release was measured in cells stimulated by PACAP. Responses were reported as fusion events per unit area. n=12 cells for scrambled shRNA and n=13 cells for IP3R1 shRNA. Differences between groups were statistically significant (Mann-Whitney, p = 7×10 -7 ).

Article Snippet: The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Cat# TR30015) is 5’-GCACTACCAGAGCTAACTCAGATAGTACT-3’, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Cat# TF517036) is 5’-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3’, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors.

Techniques: Western Blot, Control, shRNA, Expressing, Fluorescence, MANN-WHITNEY

A and B. Scatter plot of total spike area and maximum %ΔF/F of Cal520 fluorescence. Cells were stimulated by 1 μM DMPP. n=51 control (untransfected), n=12 for scrambled shRNA, n=27 for IP3R1 KD. Data are shown as medians ± interquartile range. Differences between groups were not statistically significant (Kruskal-Wallis; p > 0.05).

Journal: bioRxiv

Article Title: A PACAP-activated network for secretion requires coordination of Ca 2+ influx and Ca 2+ mobilization

doi: 10.1101/2024.01.03.574069

Figure Lengend Snippet: A and B. Scatter plot of total spike area and maximum %ΔF/F of Cal520 fluorescence. Cells were stimulated by 1 μM DMPP. n=51 control (untransfected), n=12 for scrambled shRNA, n=27 for IP3R1 KD. Data are shown as medians ± interquartile range. Differences between groups were not statistically significant (Kruskal-Wallis; p > 0.05).

Article Snippet: The scrambled shRNA and IP3R1 shRNA plasmids were purchased from OriGene; the 29mer sequence of scrambled shRNA (Cat# TR30015) is 5’-GCACTACCAGAGCTAACTCAGATAGTACT-3’, the 29mer sequence of IP3R1 (also called Itpr1) shRNA (Cat# TF517036) is 5’-TCAGCACCTTAGGCTTGGTTG-ATGACCGT-3’, and the transfected cells were identified based on their red fluorescence encoded by shRNA vectors.

Techniques: Fluorescence, Control, shRNA

Comparative real-time PCR mRNA expression of 47 genes related to contractile function in the afferent arterioles from Notch3 −/− and wild-type littermates. Note that the expression of Cacna1h coding the α 1H subunit of the T-type Ca 2+ channel (Ca v 3.2) gene was strongly downregulated in Notch3 −/− ( p < 0.001 vs. wild-type). In contrast, Cacna1c coding the α 1C subunit of the L-type Ca 2+ channel was similarly expressed in the two strains (No. 26 on the list).

Journal: International Journal of Molecular Sciences

Article Title: Deletion of Notch3 Impairs Contractility of Renal Resistance Vessels Due to Deficient Ca 2+ Entry

doi: 10.3390/ijms232416068

Figure Lengend Snippet: Comparative real-time PCR mRNA expression of 47 genes related to contractile function in the afferent arterioles from Notch3 −/− and wild-type littermates. Note that the expression of Cacna1h coding the α 1H subunit of the T-type Ca 2+ channel (Ca v 3.2) gene was strongly downregulated in Notch3 −/− ( p < 0.001 vs. wild-type). In contrast, Cacna1c coding the α 1C subunit of the L-type Ca 2+ channel was similarly expressed in the two strains (No. 26 on the list).

Article Snippet: 11 , IP3-receptor , Ip3r1 , Itpr1-Mm00439917_m1 , 0.68 ± 0.02 , 0.62 ± 0.02 , −0.12 , 0.05.

Techniques: Real-time Polymerase Chain Reaction, Expressing